Literature DB >> 1603901

Effects of trazodone on EEG sleep and clinical state in major depression.

A L van Bemmel1, R G Havermans, R van Diest.   

Abstract

The effects of the antidepressant trazodone on clinical state and on EEG sleep in eight outpatients with a major depressive disorder were investigated in a single blind study. A medication period of 5 weeks was preceded and followed by one week placebo treatment. Five subjects showed a positive treatment response. Trazodone did not influence sleep continuity and slow wave sleep, but did suppress REM sleep significantly. A significant increase of REM sleep latency was also found. These results are in contrast with earlier reports on trazodone's effects on EEG sleep but are in accordance with the general finding that antidepressants influence REM sleep characteristics without necessarily affecting sleep continuity.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1603901     DOI: 10.1007/bf02245272

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  13 in total

1.  Proposed supplements and amendments to 'A Manual of Standardized Terminology, Techniques and Scoring System for Sleep Stages of Human Subjects', the Rechtschaffen & Kales (1968) standard.

Authors:  T Hori; Y Sugita; E Koga; S Shirakawa; K Inoue; S Uchida; H Kuwahara; M Kousaka; T Kobayashi; Y Tsuji; M Terashima; K Fukuda; N Fukuda
Journal:  Psychiatry Clin Neurosci       Date:  2001-06       Impact factor: 5.188

2.  Increased deep sleep after trazodone use: a double-blind placebo-controlled study in healthy young adults.

Authors:  J C Ware; J T Pittard
Journal:  J Clin Psychiatry       Date:  1990-09       Impact factor: 4.384

3.  Effect of clomipramine on sleep and EEG power spectra in the diurnal rodent Eutamias sibiricus.

Authors:  D J Dijk; A Strijkstra; S Daan; D G Beersma; R H Van den Hoofdakker
Journal:  Psychopharmacology (Berl)       Date:  1991       Impact factor: 4.530

4.  REM sleep deprivation during 5 hours leads to an immediate REM sleep rebound and to suppression of non-REM sleep intensity.

Authors:  D G Beersma; D J Dijk; C G Blok; I Everhardus
Journal:  Electroencephalogr Clin Neurophysiol       Date:  1990-08

Review 5.  Drug effects on REM sleep and on endogenous depression.

Authors:  G W Vogel; A Buffenstein; K Minter; A Hennessey
Journal:  Neurosci Biobehav Rev       Date:  1990       Impact factor: 8.989

6.  MANOVA method for analyzing repeated measures designs: an extensive primer.

Authors:  R G O'Brien; M K Kaiser
Journal:  Psychol Bull       Date:  1985-03       Impact factor: 17.737

7.  Development of a rating scale for primary depressive illness.

Authors:  M Hamilton
Journal:  Br J Soc Clin Psychol       Date:  1967-12

8.  Sleep deprivation: effect on sleep stages and EEG power density in man.

Authors:  A A Borbély; F Baumann; D Brandeis; I Strauch; D Lehmann
Journal:  Electroencephalogr Clin Neurophysiol       Date:  1981-05

9.  Distribution of REM latency in depression.

Authors:  P A Coble; D J Kupfer; D H Shaw
Journal:  Biol Psychiatry       Date:  1981-05       Impact factor: 13.382

10.  Evidence for REM sleep deprivation as the mechanism of action of antidepressant drugs.

Authors:  G W Vogel
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  1983       Impact factor: 5.067

View more
  10 in total

Review 1.  The Black Book of Psychotropic Dosing and Monitoring.

Authors:  Alan F Schatzberg; DeBattista Charles
Journal:  Psychopharmacol Bull       Date:  2018-01-15

Review 2.  Antidepressants and sleep: a qualitative review of the literature.

Authors:  Sue Wilson; Spilios Argyropoulos
Journal:  Drugs       Date:  2005       Impact factor: 9.546

Review 3.  Trazodone for Insomnia: A Systematic Review.

Authors:  Karim Yahia Jaffer; Tiffany Chang; Brigitte Vanle; Jonathan Dang; Alexander J Steiner; Natalie Loera; Marina Abdelmesseh; Itai Danovitch; Waguih William Ishak
Journal:  Innov Clin Neurosci       Date:  2017-08-01

4.  Changes in sleep polygraphic variables and clinical state in depressed patients during treatment with citalopram.

Authors:  A L van Bemmel; R H van den Hoofdakker; D G Beersma; A L Bouhuys
Journal:  Psychopharmacology (Berl)       Date:  1993       Impact factor: 4.530

Review 5.  Trazodone. A review of its pharmacology, therapeutic use in depression and therapeutic potential in other disorders.

Authors:  M Haria; A Fitton; D McTavish
Journal:  Drugs Aging       Date:  1994-04       Impact factor: 3.923

Review 6.  Contribution of sleep research to the development of new antidepressants.

Authors:  Olivier Le Bon
Journal:  Dialogues Clin Neurosci       Date:  2005       Impact factor: 5.986

7.  Parasomnias and antidepressant therapy: a review of the literature.

Authors:  Lara Kierlin; Michael R Littner
Journal:  Front Psychiatry       Date:  2011-12-12       Impact factor: 4.157

Review 8.  Association of Sleep Architecture and Physiology with Depressive Disorder and Antidepressants Treatment.

Authors:  Peter Hutka; Michaela Krivosova; Zuzana Muchova; Ingrid Tonhajzerova; Andrea Hamrakova; Zuzana Mlyncekova; Juraj Mokry; Igor Ondrejka
Journal:  Int J Mol Sci       Date:  2021-01-29       Impact factor: 5.923

Review 9.  Rediscovering trazodone for the treatment of major depressive disorder.

Authors:  Andrea Fagiolini; Alessandro Comandini; Mario Catena Dell'Osso; Siegfried Kasper
Journal:  CNS Drugs       Date:  2012-12       Impact factor: 5.749

10.  Sleep architecture and cognitive changes in olanzapine-treated patients with depression: a double blind randomized placebo controlled trial.

Authors:  Lauren K Lazowski; Ben Townsend; Emily R Hawken; Ruzica Jokic; Regina du Toit; Roumen Milev
Journal:  BMC Psychiatry       Date:  2014-07-17       Impact factor: 3.630

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.